Want to see IN:ALKYLAMINE full AI Analyst Report?
Alkyl Amines Chemicals Limited (ALKYLAMINE) Stock Forecast & Price Target
ALKYLAMINE Analyst Ratings
There are no analyst ratings in the last 3 months.
ALKYLAMINE Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | INR 1,826→INR 1,754 | buy | 10.31%Upside | Reiterated | 10/31/26 | ||
| Google General IN | TipRanks - Google | INR 1,796→INR 1,725 | hold | 8.48%Upside | Reiterated | 10/31/26 | ||
| Anthropic General IN | TipRanks - Anthropic | INR 1,738→INR 1,670 | hold | 5.02%Upside | Reiterated | 10/31/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | INR 1,813→INR 1,741 | hold | 9.49%Upside | Reiterated | 10/31/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | INR 1,780→INR 1,709 | hold | 7.48%Upside | Reiterated | 10/31/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | INR 1,747→INR 1,678 | hold | 5.53%Upside | Reiterated | 10/31/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/31/26 | INR 1,826→INR 1,754 | buy | 10.31%Upside | Reiterated | TipRanks - PerPlexity | ||
| Google General IN | 10/31/26 | INR 1,796→INR 1,725 | hold | 8.48%Upside | Reiterated | TipRanks - Google | ||
| Anthropic General IN | 10/31/26 | INR 1,738→INR 1,670 | hold | 5.02%Upside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/31/26 | INR 1,813→INR 1,741 | hold | 9.49%Upside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/31/26 | INR 1,780→INR 1,709 | hold | 7.48%Upside | Reiterated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/31/26 | INR 1,747→INR 1,678 | hold | 5.53%Upside | Reiterated | TipRanks - xAI |
Best Analysts Covering Alkyl Amines Chemicals Limited
Copying PerPlexity General IN's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -18.70% per trade.
Copying PerPlexity General IN's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -18.70% per trade.
Copying PerPlexity General IN's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -18.70% per trade.
ALKYLAMINE Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, ALKYLAMINE has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ALKYLAMINE average Analyst price target in the past 3 months is ―.
ALKYLAMINE Financial Forecast
ALKYLAMINE Earnings Forecast
Next quarter’s earnings estimate for ALKYLAMINE is INR 13.85 with a range of INR 13.80 to INR 13.90. The previous quarter’s EPS was INR 18.75. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
ALKYLAMINE Sales Forecast
Next quarter’s sales forecast for ALKYLAMINE is INR 4.57B with a range of INR 4.10B to INR 5.11B. The previous quarter’s sales results were INR 5.28B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.